Senior Security Engineer II (Engineering & Tooling), Remote
Aledade- Full Time
- Senior (5 to 8 years)
Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. Freenome utilizes a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages. The company's mission is to drive cancer screening and save lives by building clinical, economic, and operational evidence. Their first screening test is for colorectal cancer (CRC) and advanced adenomas, with plans for further expansion. Founded in 2014, Freenome has approximately 400 employees and is growing to support its ambitious goals of providing access to better screening and earlier cancer detection. Freenome's objective is to impact patients by empowering individuals to prevent, detect, and treat their disease, fostered by a high-performing culture of respect and cross-collaboration.
The Senior Information Security Analyst is crucial in safeguarding the organization's information assets through the implementation, maintenance, and monitoring of security-related events and incidents. This role involves investigating, analyzing, and responding to cyber incidents within Freenome’s local and cloud networks or enclaves, providing expertise in evidence collection and forensic analysis. Additionally, the analyst will define and implement security controls, ensure compliance with relevant regulations and standards, and offer expertise in securing cloud and office environments. This position requires a combination of technical security skills, compliance knowledge, and a proactive approach to risk identification and mitigation.
This position reports directly to the Director of Information Security.
Security Operations:
Freenome is a high-growth biotech company dedicated to developing cancer detection tests via a standard blood draw. Their mission is to positively impact patients by enabling them to prevent, detect, and treat their diseases. The company fosters a culture characterized by respect and cross-collaboration.
Biotechnology company for early cancer detection
Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.